Early Clinical Data Raise the Bar for Hemophilia Gene Therapies
October 11, 2016
Several gene therapy companies reported promising early clinical data in July showing that they could restore healthy blood clotting factor levels in people with severe hemophilia.
Continue reading here.
The detailed scans could inspire robots and biomechanical designs.
But the rise of robots and AI may disrupt the sport’s ethos.